ℹ️
🇬🇧
Search
Search for publications relevant for "triple negative breast cancer (TNBC)"
triple negative breast cancer (TNBC)
Publication
Class
Person
Publication
Programmes
publication
Therapeutic options in patients with early breast cancer
2023 |
First Faculty of Medicine
publication
Immunotherapy in the treatment of triple negative breast cancer
2022 |
First Faculty of Medicine
publication
Hereditary breast cancer - an example of uncommon breast cancer in population
2009 |
First Faculty of Medicine
publication
Aktuální možnosti léčby metastazujícího triple negativního karcinomu prsu
2022 |
First Faculty of Medicine
publication
Predictive markers in breast cancer
2021 |
First Faculty of Medicine
publication
Triple negative breast cancer
2021 |
First Faculty of Medicine
publication
Sacituzumab govitecan
2022 |
First Faculty of Medicine
publication
Treatment strategy of triple negative breast cancer in young women - do we treat them differently?
2023 |
First Faculty of Medicine
publication
Morphological and gene-expression characterization of viable heterogeneous circulating tumor cells size-captured and cultured from triple-negative breast cancer mouse models
+1
2016 |
First Faculty of Medicine
publication
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer
2021 |
Faculty of Medicine in Hradec Králové
publication
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
2019 |
First Faculty of Medicine
publication
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness
2023 |
Second Faculty of Medicine, Faculty of Science
publication
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade
2020 |
Second Faculty of Medicine
publication
HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer
2022 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer
2015 |
Publication without faculty affiliation
publication
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study
Publication without faculty affiliation
publication
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group
2023 |
Faculty of Medicine in Pilsen
publication
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
2014 |
First Faculty of Medicine
publication
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
2022 |
Faculty of Medicine in Hradec Králové
publication
AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers
2023 |
First Faculty of Medicine